# IRME (Ir-med, Inc.) - SEC EDGAR Financial Statements

> Ir-med, Inc. reported $175K in total assets and a net loss of $2.35M through December 31, 2024 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IRME
- Markdown: https://convexityos.com/fundamentals/IRME.md
- SEC CIK: 0001839133
- Reporting currency: USD
- Latest filing period: June 30, 2025
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839133&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | -- | Dec 31, 2024 |
| Operating Income | FY 2024 | -$1.46M | Operating profit |
| Net Income | FY 2024 | -$2.35M | GAAP bottom line |
| Diluted EPS | FY 2024 | -$0.03 | Split-adjusted |
| Free Cash Flow | FY 2024 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2025 | $63K | Total debt: $42K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | $710K | $2.06M | $1.89M | $1.42M | $409K |
| **Operating Income** | -$1.94M | -$4.91M | -$4.76M | -$3.67M | -$730K |
| **EBITDA** | -$1.92M | -$4.89M | -$4.75M | -$3.67M | -$729K |
| Income Before Tax | $1.90M | $4.91M | $4.73M | $3.72M | -$752K |
| **Net Income** | -$1.90M | -$4.91M | -$4.73M | -$3.72M | -$752K |
| Basic EPS | -$0.03 | -$0.07 | -$0.07 | -$0.06 | -$0.02 |
| **Diluted EPS** | -$0.03 | -$0.07 | -$0.07 | -$0.06 | -$0.02 |
| Basic Shares Outstanding | -- | 69.4M | 67.6M | 63.1M | 30.0M |
| Diluted Shares Outstanding | 70.5M | 69.4M | 67.6M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $91K | $23K | $216K | $205K | $94K | $195K | $491K | $469K |
| **Operating Income** | -$286K | -$253K | -$324K | -$601K | -$358K | -$658K | -$1.26M | -$1.20M |
| **EBITDA** | -$282K | -$250K | -$320K | -$597K | -$354K | -$649K | -$1.26M | -$1.19M |
| **Net Income** | -$701K | -$773K | -$278K | -$598K | -$366K | -$657K | -$1.27M | -$1.18M |
| Basic EPS | -$0.01 | -$0.01 | -- | -$0.01 | -$0.01 | -$0.01 | -- | -$0.02 |
| **Diluted EPS** | -$0.01 | -$0.01 | -- | -$0.01 | -$0.01 | -$0.01 | -- | -$0.02 |
| Basic Shares Outstanding | 73.8M | 71.3M | -- | 70.8M | 70.3M | 69.9M | -- | 68.8M |
| Diluted Shares Outstanding | 73.8M | 71.3M | -- | 70.8M | 70.3M | 69.9M | -- | 68.8M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $129K | $767K | $3.00M | $2.81M | $1.87M |
| **Cash & Short-Term Investments** | $129K | $767K | $3.00M | $2.81M | $1.87M |
| Accounts Receivable, Net | $76K | $81K | $55K | $67K | $218K |
| **Total Current Assets** | $205K | $848K | $3.06M | $2.88M | $2.08M |
| Property, Plant & Equipment, Net | $35K | $56K | $71K | $31K | $6.0K |
| **Total Non-Current Assets** | $46K | $151K | $237K | $61K | $6.0K |
| **Total Assets** | $251K | $999K | $3.29M | $2.94M | $2.09M |
| Accounts Payable | $114K | $64K | $83K | $58K | $25K |
| Other Current Liabilities | -- | -- | $162K | -- | -- |
| **Total Current Liabilities** | $545K | $473K | $662K | $395K | -- |
| Long-Term Debt | -- | -- | $40K | -- | -- |
| **Total Non-Current Liabilities** | $0 | $161K | $40K | $177K | -- |
| **Total Liabilities** | $545K | $634K | $702K | $572K | $689K |
| **Total Debt (incl. Leases)** | -- | $39K | $154K | -- | -- |
| Common Stock | $70K | $69K | $68K | $64K | $54K |
| Retained Earnings | -$16.74M | -$14.84M | -$9.93M | -$5.20M | -$1.48M |
| **Total Stockholders' Equity** | -$294K | $365K | $2.59M | $2.4K | $1.40M |
| Total Equity | -$294K | $365K | $2.59M | $2.4K | $1.40M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $63K | $51K | $129K | $392K | $753K | $408K | $767K | $1.52M |
| **Cash & Short-Term Investments** | $63K | $51K | $129K | $392K | $753K | $408K | $767K | $1.52M |
| Accounts Receivable, Net | $27K | $30K | $76K | $51K | $36K | $55K | $81K | $83K |
| **Total Current Assets** | $90K | $81K | $205K | $443K | $789K | $463K | $848K | $1.61M |
| Property, Plant & Equipment, Net | $29K | $32K | $35K | $39K | $42K | $47K | $56K | $55K |
| **Total Non-Current Assets** | $85K | $43K | $46K | $90K | $98K | $116K | $151K | $166K |
| **Total Assets** | $175K | $124K | $251K | $533K | $887K | $579K | $999K | $1.77M |
| Accounts Payable | $139K | $144K | $114K | $68K | -- | -- | $64K | -- |
| **Total Current Liabilities** | $774K | $617K | $545K | -- | -- | -- | $473K | $559K |
| **Total Non-Current Liabilities** | $26K | $0 | $0 | -- | -- | -- | $161K | $2.0K |
| **Total Liabilities** | $800K | $617K | $545K | $531K | $524K | $665K | $634K | $561K |
| **Total Debt (incl. Leases)** | $42K | -- | -- | -- | -- | -- | $39K | $2.0K |
| Common Stock | $77K | $72K | $70K | $70K | $70K | $69K | $69K | $69K |
| Retained Earnings | -$18.21M | -$17.51M | -$16.74M | -$16.46M | -$15.86M | -$15.50M | -$14.84M | -$13.57M |
| **Total Stockholders' Equity** | -$625K | -$493K | -$294K | $2.0K | $363K | -$86K | $365K | $1.21M |
| Total Equity | -$625K | -$493K | -$294K | $2.0K | $363K | -$86K | $365K | $1.21M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$1.90M | -$4.91M | -$4.73M | -$3.72M | -$752K |
| Depreciation & Amortization | $21K | $17K | $10K | $5.0K | $1.0K |
| Stock-Based Compensation | $485K | $1.68M | $1.33M | $1.34M | -- |
| Change in Receivables | $6.0K | -$25K | $35K | -$38K | -$16K |
| Change in Payables | -$1.0K | $6.0K | $12K | -$83K | $320K |
| **Operating Cash Flow** | -$1.39M | -$3.23M | -$3.38M | -$2.48M | -$402K |
| Capital Expenditure | -- | -$2.0K | -$50K | -$31K | -- |
| **Free Cash Flow** | -- | -$3.23M | -$3.42M | -$2.51M | -- |
| **Investing Cash Flow** | -- | -$2.0K | -$59K | -$61K | -- |
| Common Stock Issued | -- | -- | -- | -- | $81K |
| **Financing Cash Flow** | $750K | $1.00M | $3.62M | $3.49M | $2.04M |
| **Net Change in Cash** | -$638K | -$2.23M | $187K | $949K | $1.63M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$701K | -$773K | -$278K | -$598K | -$366K | -$657K | -$1.27M | -$1.18M |
| Depreciation & Amortization | $4.0K | $3.0K | $4.0K | $4.0K | $4.0K | $9.0K | $0 | $4.0K |
| Stock-Based Compensation | $87K | $54K | -$18K | $197K | $100K | $206K | $424K | $383K |
| Change in Receivables | $3.0K | $46K | -$24K | -$15K | $18K | $27K | $3.0K | $16K |
| Change in Payables | -$50K | $40K | $57K | $10K | -$122K | $54K | $82K | -$35K |
| **Operating Cash Flow** | -$71K | -$110K | -$261K | -$395K | -$372K | -$358K | -$754K | -$811K |
| **Financing Cash Flow** | $88K | $31K | -- | -- | -- | -- | -- | -- |
| **Net Change in Cash** | $12K | -$78K | -$263K | -$361K | $345K | -$359K | -$757K | -$812K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -1344.9% | -182.6% | -156727.1% | -53.7% |
| Return on Assets (ROA) | -756.6% | -491.4% | -143.7% | -126.3% | -36.0% |
| Current Ratio | 0.38x | 1.79x | 4.62x | 7.30x | -- |
| Quick Ratio | 0.38x | 1.79x | 4.62x | 7.30x | -- |
| Debt to Equity | -- | 0.11x | 0.06x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -144600.0% | -956.7% | -- | -1344.9% | -472.6% |
| Return on Assets (ROA) | -1342.9% | -1625.0% | -756.6% | -542.6% | -391.5% | -728.2% | -491.4% | -323.1% |
| Current Ratio | 0.12x | 0.13x | 0.38x | -- | -- | -- | 1.79x | 2.87x |
| Quick Ratio | 0.12x | 0.13x | 0.38x | -- | -- | -- | 1.79x | 2.87x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.11x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
